The Ecological and Ethical Consumption Development Prospects in Poland Compared with the Western European Countries

An overview of the Western European literature shows that one of the most distinct trends in consumption that has been noted in the recent years is globally increasing environmental and social awareness. The issue of consumers' behaviours and attitudes towards "socially responsible products" has been gaining importance in Polish economy as well. This article evaluates the development prospects of ethical and ecological consumption in Poland vis-à-vis Western European countries. The comparative analysis being part of the article utilizes primary sources of information, i.e. interviews with a representative sample of Polish adults, as well as secondary sources of information. A factor analysis or, more precisely, a principal component analysis, allowed dividing Polish consumers into groups that were typologically homogeneous in respect of their sensitivity to various aspects of business ethics and ecology.Przegląd literatury zachodnio-europejskiej pozwala stwierdzić, że jednym z najbardziej zauważalnych trendów w sferze konsumpcji w ostatnich latach jest coraz większa świadomość ekologiczna i społeczna w wymiarze globalnym. Problematyka zachowań i postaw konsumentów wobec produktów "społecznie odpowiedzialnych" nabiera coraz większego znaczenia także w polskiej gospodarce. Celem artykułu jest ocena perspektyw rozwoju etyczneji ekologicznej konsumpcji w Polsce na tle krajów zachodnio-europejskich. Analizę porównawczą prowadzono bazując na źródłach wtórych jak i badaniach pierwotnych realizowanych na reprezentatywnej próbie losowej dorosłych mieszkańców Polski. W oparciu o analizę czynnikową, a dokładniej metodę analizy głównych składowych, dokonano także podziału polskich konsumentów na jednorodne grupy typologiczne pod względem ich wrażliwości na różne aspekty związane z ekologią i etyką

Conformal Rule-Based Multi-label Classification

We advocate the use of conformal prediction (CP) to enhance rule-based multi-label classification (MLC). In particular, we highlight the mutual benefit of CP and rule learning: Rules have the ability to provide natural (non-)conformity scores, which are required by CP, while CP suggests a way to calibrate the assessment of candidate rules, thereby supporting better predictions and more elaborate decision making. We illustrate the potential usefulness of calibrated conformity scores in a case study on lazy multi-label rule learning

1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis

Background: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI2 pathway. Given the previously reported anti-metastatic activity of prostacyclin (PGI2), we aimed to assess the effects of 1-MNA and its structurally related analog, 1,4-dimethylpyridine (1,4-DMP), in the prevention of cancer metastasis. Methods: All the studies on the anti-tumor and anti-metastatic activity of 1-MNA and 1,4-DMP were conducted using the model of murine mammary gland cancer (4T1) transplanted either orthotopically or intravenously into female BALB/c mouse. Additionally, the effect of the investigated molecules on cancer cell-induced angiogenesis was estimated using the matrigel plug assay utilizing 4T1 cells as a source of pro-angiogenic factors. Results: Neither 1-MNA nor 1,4-DMP, when given in a monotherapy of metastatic cancer, influenced the growth of 4T1 primary tumors transplanted orthotopically; however, both compounds tended to inhibit 4T1 metastases formation in lungs of mice that were orthotopically or intravenously inoculated with 4T1 or 4T1-luc2-tdTomato cells, respectively. Additionally, while 1-MNA enhanced tumor vasculature formation and markedly increased PGI2 generation, 1,4-DMP did not have such an effect. The anti-metastatic activity of 1-MNA and 1,4-DMP was further confirmed when both agents were applied with a cytostatic drug in a combined treatment of 4T1 murine mammary gland cancer what resulted in up to 80 % diminution of lung metastases formation. Conclusions: The results of the studies presented below indicate that 1-MNA and its structural analog 1,4-DMP prevent metastasis and might be beneficially implemented into the treatment of metastatic breast cancer to ensure a comprehensive strategy of metastasis control